Category Archives: Cell Biology

WATCH: Rachel Barnhart Runs For Mayor; Stem Cell Biology … – WXXI News

As of now shes the only candidate in the race for Rochester mayor with an actual platform. Thats according to mayoral candidate Rachel Barnhart. On this edition of Need to Know, Barnhart talks problems, priorities, and plans for Rochester if elected.

Also on the show, hes a pioneering researcher in the intriguing and at times controversial world of stem cell biology and medicine. URMCs Mark Noble explains where the stem cell movement is heading and shares new discoveries you need to know about.

View post:
WATCH: Rachel Barnhart Runs For Mayor; Stem Cell Biology ... - WXXI News

IFT20 protein’s role in helping cancer cells to invade – Medical Xpress

February 9, 2017 The functions of Ror2 and IFT20 in invasive cancer cells. In healthy cells IFT20 regulates the formation and function of primary cilia. Many cancer cells lack cilia, and these cells induce and sustain the expression of IFT20 through the high expression of Ror2. IFT20 promotes the formation of Golgi-derived microtubules by binding with the GM130-AKAP450 complex in Golgi. By doing this it regulates the deployment of Golgi and transport of proteins within Golgi, both important parts of the formation of invadopodia. Credit: Kobe University

An international research team has discovered that the IFT20 protein helps some cancer cells to invade by facilitating the transportation of membranes and proteins within parts of the cell.

Primary cilia exist on the surface of almost all human cells, acting as "cell antenna" that receive information from outside the cell. IFT20 (intraflagellar transport 20) is a protein present in most human cells that plays an essential role in the formation and functions of these primary cilia. In healthy cells it acts as a "cargo adaptor" to transport proteins along microtubules within cilia, but many cells lose these cilia when they become cancerous. This research has shed light on the function of IFT20 in non-ciliated cancer cells for the first time. The discovery has potential applications for developing new cancer treatment methods that block invasive cancer cells by targeting IFT20. The findings were published on January 26 in the online edition of Scientific Reports.

This research was carried out by an international team including Associate Professor NISHITA Michiru (Kobe University Graduate School of Medicine Department of Physiology and Cell Biology), Professor MINAMI Yasuhiro (Kobe University Graduate School of Medicine, Department of Physiology and Cell Biology), Professor Victor W. Hsu (Harvard Medical School) and Professor Gregory J. Pazour (University of Massachusetts Medical School). Most cancer-related deaths are said to be caused by cell invasion and the consequent spread of cancer cells to other parts of the body (metastasis). To counter this, scientists are searching for the mechanism that controls the invasive properties of cancer cells.

Researchers already knew that a cell membrane protein known as Ror2 expresses highly in various cancer cells, and it promotes cancer cell invasion and metastasis. Professor Nishita's team investigated various kinds of non-ciliated cancer cells and discovered that Ror2 promoted cancer cell invasiveness by inducing the expression of IFT20.

Many tumor cells break through the barrier of the extracellular matrix and infiltrate their surroundings by forming protruding structures known as invadopodia (see figure). The formation of invadopodia requires membranes and proteins supplied by the intracellular transport system, using the Golgi complex. The Golgi complex must be close to invadopodia to deploy these materials. The team's findings demonstrate that in tumor cells, IFT20 induces the Golgi complex to form microtubules by promoting interaction between the Golgi proteins GM130 and AKAP450. It also regulates the structure of the Golgi complex and transport of proteins within the complex. "This research has clarified a new molecular mechanism related to the formation of Golgi-derived microtubules, and its important role in invasive cancer cells," said Professor Nishita.

The relationship between loss of cilia and a cell's cancerous properties remains unclear. IFT20 is involved in the formation and function of cilia in healthy cells, but in non-ciliated cancer cells it is now clear that IFT20 is responsible for the formation of invadopodia. By continuing to analyze the relationship between IFT20 and the loss of cilia, this line of research could help shed light on the fundamental question of why many cancer cells lack cilia. Additionally, if the specific regulatory mechanism of IFT20 in cancer cells is revealed, this knowledge could be used to develop treatment that targets IFT20 to block invasive cancer cells.

Explore further: Study reveals gene's role in male infertility

More information: Michiru Nishita et al, Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness, Scientific Reports (2017). DOI: 10.1038/s41598-016-0028-x

Journal reference: Scientific Reports

Provided by: Kobe University

A Virginia Commonwealth University-led research team has opened a fresh direction in the field of male infertility with a new study that examines the role of a particular gene in the formation of sperm flagella, which is ...

A cellular component known as the Golgi apparatus may play a role in how lung cancer metastasizes, according to researchers at The University of Texas MD Anderson Cancer Center whose findings were reported in the Nov. 21 ...

A family of proteins called G proteins are a recognized component of the communication system the human body uses to sense hormones and other chemicals in the bloodstream and to send messages to cells. In work that further ...

Scientists at the Universities of York and Texas have found that a component of cancer cells, which acts like a 'cellular post office', could be the key to preventing the spread of lung cancer to other parts of the body.

The research, conducted at Queen Mary University of London (QMUL), found that a slight regulation in the length of primary cilia, small hair-like projections found on most cells, prevented the production of fat cells from ...

(Medical Xpress)A team of researchers affiliated with multiple institutions in Korea has found that genetically altering a type of bacteria and injecting it into cancerous mice resulted in the disappearance of tumors in ...

A single blood test and basic information about a patient's medical status can indicate which patients with myelodysplastic syndrome (MDS) are likely to benefit from a stem cell transplant, and the intensity of pre-transplant ...

A paradigm-changing Ludwig Cancer Research study reveals that short fragments of circular DNA that encode cancer genes are far more common in cancer cells than previously believed and probably play a central role in generating ...

Studies abound that point to a role for plain old aspirin in keeping deadly cancers at bay. While aspirin is not yet part of mainstream treatment for any cancer, it is recommended by the U.S. Preventive Services Task Force ...

Cancerous tumors are voracious. Once they have consumed all the oxygen and nutrients in the original tumor site, the cancer cells travel to other parts of the body (metastasize) to find more nourishment.

A QUT-driven project has identified the way in which melanoma cells spread, opening up new pathways to treatment via drugs to 'turn off' the invasive gene.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Follow this link:
IFT20 protein's role in helping cancer cells to invade - Medical Xpress

Jonathan Singer, original UCSD faculty member, dies at 92 – The San Diego Union-Tribune

Jonathan Singer, who helped build UC San Diego into a world leader in molecular and cell biology as one of the schools original biology faculty members, died Feb. 2 in La Jolla. He was 92.

Singer was on the chemistry faculty at Yale University when he was lured toUC San Diegoin 1961 by David Bonner, the founding chair of the universitys biology department.

Bonner believed that studying biology at the molecular level with chemistry as its basis would revolutionize the biological sciences and Singer, who had been mentored as a postdoctoral fellow by Nobel LaureateLinus Pauling, would be a perfect fit.

He was Bonners right-hand man and shared his vision of building a new kind of biology department focused on molecular approaches to all branches of the biological sciences, one that would be deeply interconnected by collaborative research, said Bill McGinnis, dean of the Division of Biological Sciences.

After Bonners death in 1964, Singer took over as the chair of the department and carried out much of his work, including planning the construction of the first building of the future School of Medicine.

In 1972, he and biochemist Garth Nicolson published a groundbreaking paper in Science on the Fluid Mosaic Model of the cell membrane, which would prove to explain a wide range of critical cellular processes, including cell-cell signaling, cell division, membrane budding and cell fusion.

In the last two decades of his life, Singer focused with colleague Nazneen Dewji on a novel approach to a treatment of Alzheimers disease that centered on the interaction between two cell membrane proteins beta-amyloid precursor protein and presenilin.

Singer was elected to the National Academy of Sciences in 1969 and the American Academy of Arts and Sciences in 1971, and hewon the E. B. Wilson Award from the American Society for Cell Biology in 1991.

He also was a University Professor of the University of California, an honor that has been awarded to only 41 members of the UC faculty.

He is survived by his daughter Julianne, son Matthew, niece Laura and nephew Bill, as well as granddaughter Grace and grandson Michael.

In lieu of flowers, the family requests that donations be made to the Alzheimers Association.

gary.warth@sduniontribune.com

Twitter: @GaryWarthUT

760-529-4939

Go here to read the rest:
Jonathan Singer, original UCSD faculty member, dies at 92 - The San Diego Union-Tribune

Chan Zuckerberg Biohub Awards $50M+ to 47 Investigators – Genetic Engineering & Biotechnology News

The Chan Zuckerberg Biohub (CZ Biohub) said today it will commit more than $50 million to fund human disease research by its first cohort of 47 investigators from the faculty of the University of California, Berkeley, Stanford University, and the University of California, San Francisco (UCSF).

Each investigator will receive a five-year appointment and up to $1.5 million toward life science research in their areas of expertise. CZ Biohub said the investigators were selected from several academic departments at the three universities, including biology, chemistry, computer science, engineering, mathematics, and physics.

An international panel of 60 scientists and engineers evaluated more than 700 applications, the Biohub said.

CZ Biohub investigators share our vision of a planet without disease. To realize this vision, we are giving some of the worlds most creative and brilliant researchers access to groundbreaking technology and the freedom to pursue high-risk research, Joseph DeRisi, Ph.D., of UCSF, co-president of the Biohub, said in a statement.

CZ Biohub investigators will challenge traditional thinking in pursuit of radical discoveries that will make even the most stubborn and deadly diseases treatable, added Dr. DeRisi, who co-leads the Biohub with Stephen Quake, D.Phil., of Stanford University.

The investigators have agreed to make their draft publications widely available through pre-print servers to ensure the rapid dissemination of research results, the Biohub said.

Open science will also be advanced, the Biohub added, through plans to establish share technology platforms where Bay Area scientists can further their research and advance efforts to fight disease.

In addition to its investigator program, the Biohub is pursuing large-scale collaborative projects that include an Infectious Disease Initiative and the Cell Atlas.

The Biohub says that its scientists and engineers will apply advanced technologies to fight against infectious diseases with research focused on four key areas: new detection technologies, new treatments, new ways to prevent infection, and new approaches to rapid response when new threats emerge.

Through the Cell Atlas project, the Biohub aims to build an international collaboration that will map the cell types of the human body. The map, which will be available to researchers worldwide, is intended to help researchers gain new insights into cell biology related to the causes of human disease, potentially leading to new therapies.

The Biohub was launched when Mark Zuckerberg and his wife, Priscilla Chan, M.D., set aside $600 million over 10 years toward a research center that will foster collaborations by professionals across multiple disciplines, including engineers, computer scientists, biologists, chemists, and other innovators.

The Biohub was one of two projects announced in September by the Chan Zuckerberg Initiative, named for the pediatrician and the Facebook founder, chairman, and CEO. The Initiative also committed $3 billion toward basic research over the next decade, with the audacious goal of curing, preventing, or managing all diseases by the end of the century.

More here:
Chan Zuckerberg Biohub Awards $50M+ to 47 Investigators - Genetic Engineering & Biotechnology News

Kansas, Oklahoma students honored for research in biosciences – KU Today

KANSAS CITY, KANSAS Eighteen undergraduate, graduate and postdoctoral students were honored for their scientific research presentations at the 15th annual Kansas IDeA (Institutional Development Awards) Network of Biomedical Research Excellence (K-INBRE) symposium last month in Manhattan, Kansas.

The annual symposium is part of the K-INBRE initiative to identify and recruit promising university students into careers in biomedical research in Kansas. Led by the University of Kansas Medical Center, 10 campuses in Kansas and Oklahoma participate in the collaborative network.

Developing and recruiting biomedical researchers in Kansas is a priority for the K-INBRE program, said Doug Wright, principal investigator for K-INBRE and professor and director of graduate studies in anatomy and cell biology at KU Medical Center. With this program we strive to keep the biosciences in Kansas growing and thriving.

Students work in research laboratories or in their communities alongside scientist mentors to develop research projects. These projects give students early hands-on experience in laboratory or field research practice to better inform their future career choices in the biosciences. Overall, more than 140 research posters were accepted for presentation at the symposium in a new digital poster format.

The annual K-INBRE Symposium brings together the network of students, faculty and staff from KU Medical Center, Emporia State University, Fort Hays State University, Haskell Indian Nations University, Kansas State University, Pittsburg State University, KU, Washburn University and Wichita State University as well as Langston University in Langston, Oklahoma.

The following students, listed by campus, received cash prizes for their oral and poster presentations:

University of Kansas Lawrence campus

University of Kansas Medical Center

Fort Hays State University

Kansas State University

Langston University, Langston Okla.

Washburn University

Wichita State University

K-INBRE is a multi-disciplinary network designed to inspire undergraduates to pursue careers in biomedical research, enhance research capacity through faculty development and retention and expand the biomedical research infrastructure connecting several academic institutions. More information about the program can be found at http://www.k-inbre.org.

See the article here:
Kansas, Oklahoma students honored for research in biosciences - KU Today

Use of the Quorum Cryo-SEM preparation system in microbial cell biology with electron cryotomography at the Jensen … – News-Medical.net

Quorum Technologies, market and technology leaders in electron microscopy coating and cryogenic preparation products, report on how their PP3010T Cryo-SEM preparation system is being used in the preparation of hydrated whole cells to be imaged using electron cryotomography in the Jensen Laboratory located at HHMI Caltech.

Image of fission yeast Schizosaccharomyces pombe cells prepared for TEM - by Vitrobot freezing on Quantifoil grids and Quorum PP3010T transfer for FEI Versa FIB milling.

Alasdair McDowall is the EM Center Director in the Jensen Laboratory at the Howard Hughes Medical Institute located at Caltech. Headed by Professor Grant Jensen, the Lab uses Electron Cryotomography (ECT) to study the molecular architecture of microbial cells and HIV in their native state. The focus is on the fundamentals of microbial cell biology such as cell division, movement and secretion, as well as the structure of HIV at all stages of its lifecycle.

The lab opened its doors in 2002 and continues to push the boundaries of high resolution imaging today. However, the investigation of frozen hydrated whole cells (beam and vacuum sensitive materials) in the electron microscope chamber requires new solutions. The advances in techniques for the preparation of cells by Cryo Focused Ion Beam Milling for structural characterization have recently provided a new insight of these delicate cellular architectures.

Image of fission yeast Schizosaccharomyces pombe cells prepared for TEM - by Vitrobot freezing on Quantifoil grids and Quorum PP3010T transfer for FEI Versa FIB milling.

Cryo Focused Ion Beam milling (cryo FIB milling) is a cutting-edge method for thinning vitrified biological samples that allows access to intracellular regions of thick specimens (> 1 um) with unprecedented ease and structural preservation. It provides the ability to move beyond imaging only small bacterial cells with electron cryotomography (ECT) and will allow the exploration of eukaryotic cells, tissues and microbial biofilms to the same molecular resolution that the group has achieved with individual bacterial cells for the past decade.

In addition, the ability to thin individual bacterial cells before imaging, without perturbing their structure, will provide higher contrast and resolution when necessary, even within already thin bacterial cells. Furthermore, the addition of a cryo-stage to the existing FIB mill at Caltech will allow for further development of much needed methods for correlating fluorescence microscopy and electron tomography for the targeting and identification of specific structures deep within eukaryotic cells, bacteria and tissues.

Image of fission yeast Schizosaccharomyces pombe cells prepared for TEM - by Vitrobot freezing on Quantifoil grids and Quorum PP3010T transfer for FEI Versa FIB milling.

Dr McDowall uses the Quorum PP3010T cryo sample preparation system. This is a highly automated, easy-to-use, column-mounted, gas-cooled Cryo-SEM preparation system suitable for most makes and models of SEM, FE-SEM and FIB/SEM. The Jensen group uses their prep system with an FEI Versa scanning electron microscope.

Dr McDowall

To obtain full details of Cryo-SEM preparation systems and other products available from Quorum Technologies, please visit http://www.quorumtech.com.

Acknowledgements: Quorum Technologies thanks the following for sharing their research: Professors Grant Jensen & Julia Greer and Drs Matt Swuilius, Shrawan Mageswaran & Wei Zhao.

Excerpt from:
Use of the Quorum Cryo-SEM preparation system in microbial cell biology with electron cryotomography at the Jensen ... - News-Medical.net

Bakar Fellow: Aiding cells’ strategy to survive – Phys.Org

February 6, 2017 by Wallace Ravven James Hurleys lab has determined the molecular structure of the site where production of bubble-shaped autophagosomes begins in cells organelles essential to rid the cells of debris. Credit: University of California - Berkeley

As any human biology text will tell you, enzymes in the stomach and intestine break down proteins that are locked into almost every bite we eat. The proteins' amino acid building blocks are then transported to the body's hungry cells.

There, construction begins anew as cell machinery reassembles new proteins for whatever tasks the genes call: ramping up energy production, ferrying materiel to different cell siteseven switching gene activity on or off.

But cells don't consume every protein they are offered, and leftovers can build up, clogging metabolism and threatening cell survival. Protein production can also go awry. Some must be disassembled in the cell and rebuilt, often leaving bits and pieces on the factory floor.

The Bakar Fellows Program supports research by biochemist James Hurley, professor of molecular and cell biology, to develop a new drug to boost the natural process that sweeps these threats away.

A cell's failure to clean house poses other direct threats to survival. Over the course of its life, a cell's machinery runs down. Mitochondria, the cell's powerhouses, falter and free charged atoms and molecules known as oxygen free radicals to indiscriminately destroy proteins. The cell is all but doomed.

"You don't want your cells filling up with failed mitochondria or unused protein fragments," Hurley says.

The natural, life-saving process called autophagy cleans the table, carrying out two crucial roles at the same time. It spares the cell from multiple insults, and makes leftovers available for re-usea boon when food is scarce.

The key player in autophagy is callednot surprisinglyan autophagosome. The autophagosome is a bubble-shaped sac that engulfs left-over amino acids, spent mitochondria and other materiel, and ferries them to recycling sites. An autophagosome "can fit snugly around a single mitochondrion," Hurley says.

But as in every cell function, this too can fail. Neurons are particularly at risk, possibly due to the distance autophagosomes must travel through the cells' long dendrites and axons to bring their cargoes back to the cell body.

Studies in mice show that failed or sluggish autophagy causes neuron death. Inefficient autophagy may also drive the build-up of protein aggregates in neurons that is thought to cause Parkinson's disease.

Synthesis of autophagosomes in the cell is the result of an interaction between two protein complexeseach itself made up of several proteins. Hurley's lab has used a variety of techniqueselectron microscopy, x-ray crystallography, spectroscopy and live-cell imagingto clarify the atomic-level structure of these two units and their interaction. His research suggests that autophagosome synthesis is directly related to the distance between key sites in these two units.

The structural insights have led his lab to new research, funded by the Bakar Fellows Program, to develop a drug that can change the units' 3-D shapes and bring them into the "activated" shape or conformation. This conformation, he thinks, would increase the cell's production of autophagosomes.

The approach is unusual. Most pharmaceutical interest in these complexes has focused on strategies to thwart cancer growth by preventing the two complexes from becoming activeswitching off autophagosome production.

"It's much easier to turn off the signal than turn it on," Hurley says, and the effort to do so by changing the conformation of the two protein complexes is a young field made possible by powerful structural imaging techniques.

The entire process of assembling the autophagosome takes only about ten minutes, which makes sense from an evolutionary perspective, Hurley says. Starvation can snap the cell's autophagy machinery into action, quickly yielding nutrients to sustain cells, and allow the personor mouse or whalethey reside in to hunt for more substantial food.

While nutrient need and the threat of spent materials drive autophagy, recent research has shown that other factors can trigger the process. Calorie-restriction diets and exercise trigger production of autophagosomes, Hurley says.

These recent, "optional" activities mimic starvation that threatened ancestors at some point, and, sadly, continue to do so in many cultures today. In societies with readily available food, autophagy's ability to quickly provide more nutrients is far less important than its ability to clear cells of debris.

"If neurons can't rid themselves of failing mitochondria, this defect will lead to disease, or worse," he says. "We think we can develop a drug to reverse this threat."

Explore further: Researchers identify process cells use to destroy damaged organelles, with links to diseases

Researchers at UT Southwestern Medical Center have uncovered the mechanism that cells use to find and destroy an organelle called mitochondria that, when damaged, may lead to genetic problems, cancer, neurodegenerative diseases, ...

In a recent Science Advances article, Mayo Clinic researchers show how hungry human liver cells find energy. This study, done in rat and human liver cells, reports on the role of a small regulatory protein that acts like ...

Several well-known neurodegenerative diseases, such as Lou Gehrig's (ALS), Parkinson's, Alzheimer's, and Huntington's disease, all result in part from a defect in autophagy - one way a cell removes and recycles misfolded ...

(Medical Xpress) -- New research from scientists at the University of Cambridge provides critical insight into the formation of autophagosomes, which are responsible for cleaning up cellular waste.

A protein linked to Parkinson's disease may cause neurodegeneration by inhibiting autophagy -- the process in which cells digest some of their contents -- according to a study in the September 20 issue of the Journal of Cell ...

Cells use various methods to break down and recycle worn-out componentsautophagy is one of them. In the dissertation she will be defending at Umea University in Sweden, Karin Hberg shows that the protein SNX18 ...

The concept behind microbial fuel cells, which rely on bacteria to generate an electrical current, is more than a century old. But turning that concept into a usable tool has been a long process. Microbial fuel cells, or ...

Digging around in the dark can sometimes lead to interesting results: in the acidic waters of an abandoned coal mine in Kentucky (USA), researchers discovered ten previously unknown microbial natural products from a strain ...

Can helium bond with other elements to form a stable compound? Students attentive to Utah State University professor Alex Boldyrev's introductory chemistry lectures would immediately respond "no." And they'd be correct ...

Chemists scouring Appalachia for exotic microorganisms that could yield blockbuster drugs have reported a unique find from the smoldering remains of a coal mine fire that's burned for nearly a decade in southeastern Kentucky.

A team of scientists from the Energy Department's National Renewable Energy Laboratory (NREL) determined that surface recombination limits the performance of polycrystalline perovskite solar cells.

A compound found in green tea could have lifesaving potential for patients with multiple myeloma and amyloidosis, who face often-fatal medical complications associated with bone-marrow disorders, according to a team of engineers ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

More:
Bakar Fellow: Aiding cells' strategy to survive - Phys.Org

Gene therapy allows ‘deaf’ mice to hear – Wired.co.uk

Getty Images / De Agostini Picture Library / Contributor

Hearing loss affects millions of people around the world, and in around half of those cases the root cause is genetic. Now, medical researchers have been able to restore the hearing and balance in mice by inserting mutated genes into their bodies. Two papers published in the Nature Biotechnology journal describe the results.

"We demonstrate recovery of gene and protein expression, restoration of sensory cell function, rescue of complex auditory function and recovery of hearing and balance behaviour to near wild-type levels," otolaryngologists from the Harvard Medical School say in the research paper.

It says the work shows an "unprecedented recovery of inner ear function" and claims the "biological therapies to treat deafness may be suitable for translation to humans".

During the work, young mice were used to prove the method works. The mice had been artificially administered with Usher syndrome type IC, which in human children causes deafness, balance dysfunction, and blindness.

Most people born with type I and type II Usher syndrome suffer with severe to profound hearing loss as well as vision problems. Those with type III experience hearing loss later in life. The work from the Harvard medical academics focussed purely on the hearing loss aspect of the syndrome.

Subscribe to WIRED

To tackle the deafness, the research team injected a synthetic version of the adeno-associated virus - which has very little impact on humans - into the ears of mice. Within the virus was a normal copy of the mutated Ush1c gene, which causes deafness in the syndrome. It was the first time scientists have been able to find a virus that can enter the inner ear and deliver genes to the inner and outer hair cells needed for normal hearing ability.

"Delivery of a normal copy of the mutated gene, Ush1c, to the cochlea soon after the mice were born led to high levels of Ush1c protein in outer and inner hair cells, repair of damaged hair cell bundles, and a robust improvement in hearing and balance behaviour, enabling profoundly deaf mice to hear sounds at the level of whispers," a statement published alongside the research said.

"They can restore the hearing defect by the gene transfer," Andrew Forge an emeritus professor of auditory cell biology at University College London and author on the first Nature paper, tells WIRED.

Ruth Taylor, another UCL researcher involved in the work, tested the gene transfer method with human tissue. Using vestibular tissue the UCL academics were able to show the virus could transfer the gene to the human tissue in culture. "They did a lot of proof of concept in mice," Forge says. "The bit we did is the extra bit to show this could work in people."

He explains the work - and the field in general - is trying to answer one big question: "Can you manipulate the system to cure things that are wrong?"

Forge adds: "These kinds of therapies, if there is going to be a therapy, will be the way it is going to be working".

See the original post:
Gene therapy allows 'deaf' mice to hear - Wired.co.uk

Life Science Reference – Biology Online

Biology-Online.org is run by enthusiasts from all around the world and visited by over 25,000 people every day. Please help us grow our content! Submit your own articles, tutorials, essays, reports or any other biology related work and we will publish it online in the appropriate section.

World's largest and most comprehensive biology discussion board, made up of sections on Cell Biology, Molecular Biology, Zoology, Evolution, Microbiology, Bioinformatics, Human Biology, Botany, Genetics, Physiology, Ecology and others. Go to Forum.

Trending discussion:

Our editable Wiki Dictionary provides explanations for thousands of terms with links to relevant tutorials. Help us make this dictionary more comprehensive by editing its content. All changes are monitored by moderators. Go to Wiki Dictionary.

Quick Wiki Dictionary Links: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9 OTHER

This section contains hand picked articles in Agriculture, Astrobiology, Biochemistry, Bioengineering, Biophysics, Health and Medicine and many other topics. Our administrators add new articles daily. Submit your own work including articles, essays, assignments, PHD research or anything else related to biology, and help us grow this section. Go to Articles.

The biology tutorials aim to give an introductory to intermediate understanding of various biological concepts and disciplines, split up into sections for ease of use. Within each tutorial are references to the biology dictionary, intending to give an easy reference to the terminology used. Read tutorials.

Browse through our extensive book catalogue which covers all aspects of biological sciences. Read expert and consumer reviews and ratings. Go to Books.

Use this directory to find external links and resources to a broad range of Earth and Life Science websites. The sites are split up categorically to help you pinpoint the web page that discusses the subject you are interested in. Go to the Directory.

Go here to read the rest:
Life Science Reference - Biology Online